Interleukin-3 Human (recombinant)
Interleukin-3 Human (recombinant) Uses, Dosage, Side Effects, Food Interaction and all others data.
Interleukin-3 Human (recombinant) is under investigation in clinical trial NCT00002258 (A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in HIV Infected Patients With Cytopenia).
| Trade Name | Interleukin-3 Human (recombinant) |
| Generic | Muplestim |
| Muplestim Other Names | Human interleukin-3 (nonglycosylated), Interleukin 3, Interleukin 3 (human), Interleukin-3, Interleukin-3 human (recombinant), Multipotential colony-stimulating factor, Muplestim |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Interleukin-3 Human (recombinant)
